US Stock MarketDetailed Quotes

Arcus Biosciences (RCUS)

Watchlist
  • 25.500
  • +0.370+1.47%
Close Apr 24 16:00 ET
  • 25.750
  • +0.250+0.98%
Post 17:03 ET
3.20BMarket Cap-7.75P/E (TTM)

Arcus Biosciences (RCUS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-183.53%-482M
-20.00%-120M
-473.08%-97M
-41.49%-133M
-6,500.00%-132M
44.44%-170M
-13.64%-100M
141.27%26M
-64.91%-94M
97.96%-2M
Net income from continuing operations
-24.73%-353M
-12.77%-106M
-46.74%-135M
--0
-2,700.00%-112M
7.82%-283M
-16.05%-94M
-29.58%-92M
-24.00%-93M
95.00%-4M
Depreciation and amortization
0.00%10M
0.00%3M
0.00%2M
0.00%2M
0.00%3M
25.00%10M
0.00%3M
100.00%2M
0.00%2M
50.00%3M
Other non cash items
-20.00%8M
-66.67%1M
100.00%4M
-66.67%1M
0.00%2M
0.00%10M
50.00%3M
-33.33%2M
50.00%3M
-33.33%2M
Change In working capital
-981.82%-194M
-30.43%-30M
-79.21%21M
-678.95%-148M
0.00%-37M
130.99%22M
4.17%-23M
1,222.22%101M
---19M
2.63%-37M
-Change in receivables
-67.86%9M
--0
-66.67%4M
--0
-61.54%5M
86.67%28M
---4M
9.09%12M
450.00%7M
116.67%13M
-Change in payables and accrued expense
700.00%24M
--0
1,400.00%13M
--8M
400.00%3M
400.00%3M
150.00%5M
-116.67%-1M
--0
-110.00%-1M
-Change in other current assets
-77.27%5M
--0
500.00%6M
-110.00%-1M
--0
257.14%22M
400.00%6M
109.09%1M
42.86%10M
162.50%5M
-Change in other current liabilities
-68.00%8M
-133.33%-4M
9.09%24M
66.67%5M
-41.67%-17M
933.33%25M
271.43%12M
29.41%22M
-62.50%3M
42.86%-12M
-Change in other working capital
-328.57%-240M
38.10%-26M
-138.81%-26M
-310.26%-160M
33.33%-28M
17.65%-56M
-147.06%-42M
309.38%67M
-750.00%-39M
-68.00%-42M
Cash from discontinued investing activities
Operating cash flow
-183.53%-482M
-20.00%-120M
-473.08%-97M
-41.49%-133M
-6,500.00%-132M
44.44%-170M
-13.64%-100M
141.27%26M
-64.91%-94M
97.96%-2M
Investing cash flow
Cash flow from continuing investing activities
178.57%66M
-456.86%-182M
372.41%79M
117.46%137M
118.93%32M
-143.30%-84M
82.14%51M
-363.64%-29M
142.31%63M
-231.01%-169M
Net PPE purchase and sale
66.67%-2M
0.00%-1M
--0
--0
75.00%-1M
75.00%-6M
83.33%-1M
90.00%-1M
--0
-33.33%-4M
Net investment purchase and sale
187.18%68M
-448.08%-181M
382.14%79M
117.46%137M
120.00%33M
-135.78%-78M
52.94%52M
-233.33%-28M
103.23%63M
-225.00%-165M
Cash from discontinued investing activities
Investing cash flow
178.57%66M
-456.86%-182M
372.41%79M
117.46%137M
118.93%32M
-143.30%-84M
82.14%51M
-363.64%-29M
142.31%63M
-231.01%-169M
Financing cash flow
Cash flow from continuing financing activities
76.17%488M
14,400.00%286M
-83.33%8M
2,500.00%52M
-37.99%142M
739.39%277M
-166.67%-2M
700.00%48M
-91.30%2M
22,800.00%229M
Net issuance payments of debt
4.26%49M
--0
--0
----
----
--47M
--0
--47M
----
----
Net common stock issuance
88.16%429M
--279M
--8M
--0
-37.72%142M
812.00%228M
--0
--0
--0
--228M
Proceeds from stock option exercised by employees
11.11%10M
133.33%7M
--0
0.00%3M
--0
12.50%9M
0.00%3M
100.00%2M
0.00%3M
0.00%1M
Net other financing activities
----
----
----
----
----
---7M
---5M
---1M
----
----
Cash from discontinued financing activities
Financing cash flow
76.17%488M
14,400.00%286M
-83.33%8M
2,500.00%52M
-37.99%142M
739.39%277M
-166.67%-2M
700.00%48M
-91.30%2M
22,800.00%229M
Net cash flow
Beginning cash position
17.69%153M
18.14%241M
57.86%251M
3.72%195M
17.69%153M
-37.80%130M
9.09%204M
-31.76%159M
-21.99%188M
-37.80%130M
Current changes in cash
213.04%72M
68.63%-16M
-122.22%-10M
293.10%56M
-27.59%42M
129.11%23M
10.53%-51M
197.83%45M
-262.50%-29M
81.25%58M
End cash Position
47.06%225M
47.06%225M
18.14%241M
57.86%251M
3.72%195M
17.69%153M
17.69%153M
9.09%204M
-31.76%159M
-21.99%188M
Free cash flow
-175.00%-484M
-19.80%-121M
-488.00%-97M
-41.49%-133M
-2,116.67%-133M
46.67%-176M
-7.45%-101M
134.25%25M
-51.61%-94M
94.06%-6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -183.53%-482M-20.00%-120M-473.08%-97M-41.49%-133M-6,500.00%-132M44.44%-170M-13.64%-100M141.27%26M-64.91%-94M97.96%-2M
Net income from continuing operations -24.73%-353M-12.77%-106M-46.74%-135M--0-2,700.00%-112M7.82%-283M-16.05%-94M-29.58%-92M-24.00%-93M95.00%-4M
Depreciation and amortization 0.00%10M0.00%3M0.00%2M0.00%2M0.00%3M25.00%10M0.00%3M100.00%2M0.00%2M50.00%3M
Other non cash items -20.00%8M-66.67%1M100.00%4M-66.67%1M0.00%2M0.00%10M50.00%3M-33.33%2M50.00%3M-33.33%2M
Change In working capital -981.82%-194M-30.43%-30M-79.21%21M-678.95%-148M0.00%-37M130.99%22M4.17%-23M1,222.22%101M---19M2.63%-37M
-Change in receivables -67.86%9M--0-66.67%4M--0-61.54%5M86.67%28M---4M9.09%12M450.00%7M116.67%13M
-Change in payables and accrued expense 700.00%24M--01,400.00%13M--8M400.00%3M400.00%3M150.00%5M-116.67%-1M--0-110.00%-1M
-Change in other current assets -77.27%5M--0500.00%6M-110.00%-1M--0257.14%22M400.00%6M109.09%1M42.86%10M162.50%5M
-Change in other current liabilities -68.00%8M-133.33%-4M9.09%24M66.67%5M-41.67%-17M933.33%25M271.43%12M29.41%22M-62.50%3M42.86%-12M
-Change in other working capital -328.57%-240M38.10%-26M-138.81%-26M-310.26%-160M33.33%-28M17.65%-56M-147.06%-42M309.38%67M-750.00%-39M-68.00%-42M
Cash from discontinued investing activities
Operating cash flow -183.53%-482M-20.00%-120M-473.08%-97M-41.49%-133M-6,500.00%-132M44.44%-170M-13.64%-100M141.27%26M-64.91%-94M97.96%-2M
Investing cash flow
Cash flow from continuing investing activities 178.57%66M-456.86%-182M372.41%79M117.46%137M118.93%32M-143.30%-84M82.14%51M-363.64%-29M142.31%63M-231.01%-169M
Net PPE purchase and sale 66.67%-2M0.00%-1M--0--075.00%-1M75.00%-6M83.33%-1M90.00%-1M--0-33.33%-4M
Net investment purchase and sale 187.18%68M-448.08%-181M382.14%79M117.46%137M120.00%33M-135.78%-78M52.94%52M-233.33%-28M103.23%63M-225.00%-165M
Cash from discontinued investing activities
Investing cash flow 178.57%66M-456.86%-182M372.41%79M117.46%137M118.93%32M-143.30%-84M82.14%51M-363.64%-29M142.31%63M-231.01%-169M
Financing cash flow
Cash flow from continuing financing activities 76.17%488M14,400.00%286M-83.33%8M2,500.00%52M-37.99%142M739.39%277M-166.67%-2M700.00%48M-91.30%2M22,800.00%229M
Net issuance payments of debt 4.26%49M--0--0----------47M--0--47M--------
Net common stock issuance 88.16%429M--279M--8M--0-37.72%142M812.00%228M--0--0--0--228M
Proceeds from stock option exercised by employees 11.11%10M133.33%7M--00.00%3M--012.50%9M0.00%3M100.00%2M0.00%3M0.00%1M
Net other financing activities -----------------------7M---5M---1M--------
Cash from discontinued financing activities
Financing cash flow 76.17%488M14,400.00%286M-83.33%8M2,500.00%52M-37.99%142M739.39%277M-166.67%-2M700.00%48M-91.30%2M22,800.00%229M
Net cash flow
Beginning cash position 17.69%153M18.14%241M57.86%251M3.72%195M17.69%153M-37.80%130M9.09%204M-31.76%159M-21.99%188M-37.80%130M
Current changes in cash 213.04%72M68.63%-16M-122.22%-10M293.10%56M-27.59%42M129.11%23M10.53%-51M197.83%45M-262.50%-29M81.25%58M
End cash Position 47.06%225M47.06%225M18.14%241M57.86%251M3.72%195M17.69%153M17.69%153M9.09%204M-31.76%159M-21.99%188M
Free cash flow -175.00%-484M-19.80%-121M-488.00%-97M-41.49%-133M-2,116.67%-133M46.67%-176M-7.45%-101M134.25%25M-51.61%-94M94.06%-6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More